153 related articles for article (PubMed ID: 34126643)
41. Cordycepin from Cordyceps militaris ameliorates diabetic nephropathy via the miR-193b-5p/MCL-1 axis.
Zheng R; Zhang W; Song J; Zhong Y; Zhu R
Chin Med; 2023 Oct; 18(1):134. PubMed ID: 37833817
[TBL] [Abstract][Full Text] [Related]
42. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
43. Potential Repressive Impact of microRNA-20a on Renal Tubular Damage in Diabetic Kidney Disease by Targeting C-X-C Motif Chemokine Ligand 6.
Wang SZ; Zhang YL; Shi HB
Arch Med Res; 2021 Jan; 52(1):58-68. PubMed ID: 32868134
[TBL] [Abstract][Full Text] [Related]
44. Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway.
Ning Y; Zhou X; Wang G; Zhang L; Wang J
Curr Gene Ther; 2024; 24(2):159-177. PubMed ID: 37767799
[TBL] [Abstract][Full Text] [Related]
45. Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response.
Lin M; Song D; Zhang S; Li P
Diabetol Metab Syndr; 2021 Oct; 13(1):122. PubMed ID: 34715911
[TBL] [Abstract][Full Text] [Related]
46. MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.
Zhao N; Luo Q; Lin R; Li Q; Ma P
Clin Exp Nephrol; 2021 Nov; 25(11):1182-1192. PubMed ID: 34145485
[TBL] [Abstract][Full Text] [Related]
47. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
49. Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte.
Duan YR; Chen BP; Chen F; Yang SX; Zhu CY; Ma YL; Li Y; Shi J
J Cell Mol Med; 2021 Dec; 25(23):10798-10813. PubMed ID: 31568645
[TBL] [Abstract][Full Text] [Related]
50. High Glucose-Induced Apoptosis in Human Kidney Cells Was Alleviated by miR-15b-5p Mimics.
Shen H; Fang K; Guo H; Wang G
Biol Pharm Bull; 2019 May; 42(5):758-763. PubMed ID: 30842352
[TBL] [Abstract][Full Text] [Related]
51. CircACTR2 attenuated the effects of tetramethylpyrazine on human kidney cell injury.
Chen X; Zou B; Yang Z
J Bioenerg Biomembr; 2024 Jun; 56(3):273-284. PubMed ID: 38427129
[TBL] [Abstract][Full Text] [Related]
52. GDF11, a target of miR-32-5p, suppresses high-glucose-induced mitochondrial dysfunction and apoptosis in HK-2 cells through PI3K/AKT signaling activation.
Wang H; Zhang Y; Liu H; Li S
Int Urol Nephrol; 2023 Jul; 55(7):1767-1778. PubMed ID: 36749472
[TBL] [Abstract][Full Text] [Related]
53. Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysine 63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy.
Pontrelli P; Oranger A; Barozzino M; Divella C; Conserva F; Fiore MG; Rossi R; Papale M; Castellano G; Simone S; Laviola L; Giorgino F; Piscitelli D; Gallone A; Gesualdo L
J Mol Med (Berl); 2018 Jul; 96(7):645-659. PubMed ID: 29806072
[TBL] [Abstract][Full Text] [Related]
54. LncRNA KCNQ1OT1 promotes the development of diabetic nephropathy by regulating miR-93-5p/ROCK2 axis.
Zhao L; Chen H; Wu L; Li Z; Zhang R; Zeng Y; Yang T; Ruan H
Diabetol Metab Syndr; 2021 Oct; 13(1):108. PubMed ID: 34654473
[TBL] [Abstract][Full Text] [Related]
55. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
56. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.
Wang J; Wang G; Liang Y; Zhou X
J Diabetes Res; 2019; 2019():5204394. PubMed ID: 31218232
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
[TBL] [Abstract][Full Text] [Related]
58. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
[TBL] [Abstract][Full Text] [Related]
59. Circ-FBXW12 aggravates the development of diabetic nephropathy by binding to miR-31-5p to induce LIN28B.
Sun A; Sun N; Liang X; Hou Z
Diabetol Metab Syndr; 2021 Dec; 13(1):141. PubMed ID: 34863268
[TBL] [Abstract][Full Text] [Related]
60. Circ ASAP2 decreased inflammation and ferroptosis in diabetic nephropathy through SOX2/SLC7A11 by miR-770-5p.
Li Q; Meng X; Hua Q
Acta Diabetol; 2023 Jan; 60(1):29-42. PubMed ID: 36153434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
